WebApr 8, 2024 · Focused on the generation of new anticancer prodrugs, the ICT-DTC has been created following a major £2m investment by ICT spin-out company Incanthera Ltd. We are now looking for applications ... WebIncanthera debuts...Newco Incanthera Ltd. (Merseyside, U.K.) raised L375,000 ($574,000) in a seed round led by the North West Fund for Biomedical... Read More. BioCentury Jan 9, 2012. Financial News. Ai2 completes venture financing
Incanthera - Funding, Financials, Valuation & Investors - CrunchBase
WebIncanthera is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. We … WebApr 13, 2024 · Incanthera plc is a United Kingdom-based dermatology and oncology therapeutics company. The Company is focused on drug discovery and the development of targeted medicines for the treatment of... onomichi sushi
Incanthera PLC, INC:NXX summary - FT.com - Financial Times
WebFeb 28, 2024 · Developer Incanthera Class Antineoplastics; Colchicum alkaloids; Drug conjugates; Peptides Mechanism of Action Vascular disrupting agents Orphan Drug Status No New Molecular Entity Yes Highest Development Phases No development reported Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer Most Recent Events WebThe pipeline guide evaluates Bladder Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. WebNov 8, 2015 · This report provides comprehensive information on the current therapeutic developmental pipeline of Incanthera Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. onomotion.com